Kodishala C, Jose George R, Javed R, Lovering E J, Crowson C S, Lennon R J, Hulshizer C A, Myasoedova E
Division of Rheumatology, Mayo Clinic, Rochester, MN, USA.
Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
Scand J Rheumatol. 2025 Jun 3:1-8. doi: 10.1080/03009742.2025.2503055.
Several studies have reported an association between rheumatoid arthritis (RA) disease activity and the risk of Alzheimer's disease and related dementias (AD/ADRD). We examined the role of RA flares on the risk of AD/ADRD.
This population-based study was conducted on an inception cohort of RA patients aged ≥ 50 years, who were residents of Minnesota, USA (1988-2014). RA-related flare/remission status was ascertained via medical record review. In definition 1, flares were considered to start on the day of documentation and resolve halfway to the next visit. In definition 2, 'acute flares' were defined as lasting for 6 weeks. Incident dementia was defined by the presence of two ICD-9/10 codes for AD/ADRD ≥ 30 days apart. Cox models were used to assess the association of RA flares with AD/ADRD.
We included 774 patients with RA. During a median follow-up of 7.8 years, 79 patients (10%) developed AD/ADRD. During a total of 12 437 medical visits, patients were flaring at 3407 visits (27.4%) and in remission at 2900 visits (23.3%). Using definition 1, we found no significant evidence of a higher risk of incident AD/ADRD when in RA flare versus remission [hazard ratio (HR) 1.11, 95% confidence interval (CI) 0.63-1.96]. Using definition 2, patients with RA flare had an estimated 1.8-fold increased risk of AD/ADRD (HR 1.82, 95% CI 0.82-4.06) versus remission, which was not statistically significant.
We found that RA flares are common. A detrimental effect of active flares on cognitive status cannot be excluded.
多项研究报告了类风湿关节炎(RA)疾病活动与阿尔茨海默病及相关痴呆症(AD/ADRD)风险之间的关联。我们研究了RA病情发作对AD/ADRD风险的影响。
这项基于人群的研究针对美国明尼苏达州年龄≥50岁的RA患者起始队列进行(1988 - 2014年)。通过病历审查确定与RA相关的病情发作/缓解状态。在定义1中,病情发作被认为从记录之日开始,并在下一次就诊中途缓解。在定义2中,“急性发作”定义为持续6周。新发痴呆症通过出现两个间隔≥30天的AD/ADRD的ICD - 9/10编码来定义。使用Cox模型评估RA病情发作与AD/ADRD的关联。
我们纳入了774例RA患者。在中位随访7.8年期间,79例患者(10%)发生了AD/ADRD。在总共12437次就诊中,患者在3407次就诊时病情发作(27.4%),在2900次就诊时处于缓解期(23.3%)。使用定义1,我们未发现有显著证据表明与处于缓解期相比,RA病情发作时新发AD/ADRD的风险更高[风险比(HR)1.11,95%置信区间(CI)0.63 - 1.96]。使用定义2,与缓解期相比,RA病情发作的患者发生AD/ADRD的风险估计增加1.8倍(HR 1.82,95% CI 0.82 - 4.06),但无统计学意义。
我们发现RA病情发作很常见。不能排除活动期发作对认知状态的有害影响。